JPRN-UMIN000019137已完成2 期
Japanese study to evaluate the utility of eribulin dose and schedule in treatment for advanced breast cancer patients(JUST-STUDY)-additional research on patients enrolled in JUST-STUDY- - Japanese study to evaluate the utility of eribulin dose and schedule in treatment for advanced breast cancer patients(JUST-STUDY)-additional research on patients enrolled in JUST-STUDY
PO Advanced Clinical Reserch Organization0 个研究点目标入组 88 人开始时间: 2015年9月28日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 88
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Japanese study to evaluate the utility of eribulin dose and schedule in treatment for advanced breast cancer patientsbreast cancerJPRN-UMIN000008491PO Advanced Clinical Reserch Organization80
未知
2 期
A study to evaluate the efficacy of Eribulin retreatment in HER2 negative Metastatic Breast Cancer patients - Phase II studyHER2-negative metastatic breast cancerJPRN-UMIN000027165Toho university30
已完成
不适用
A Phase II Study of Eribulin Evaluating Efficacy and Safety as first or secondary line chemotherapy for advanced or metastatic breast cancer without HER2 overexpressingAdvanced or metastatic breast cancerJPRN-UMIN000009568General and Gastroenterological Surgery, Osaka Medical College35
已完成
不适用
Evaluation of safety and efficacy of eribulin for patients advanced or recurrent HER2 negative breast cancer who have been treated with anthracyclines and taxanesBreast cancerJPRN-UMIN000007121Kyushu Breast Cancer Study Group50
已完成
不适用
The Japanese randomized trial for evaluating the Efficacy of low-dose thoracic CT Screening for lung cancerung cancerJPRN-UMIN000005909The JECS Study Group27,000